Search by Drug Name or NDC
NDC 13107-0082-05 TRAZODONE HYDROCHLORIDE 300 mg/1 Details
TRAZODONE HYDROCHLORIDE 300 mg/1
TRAZODONE HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurolife Pharma LLC. The primary component is TRAZODONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Trazodone is used to treat depression. Trazodone is in a class of medications called serotonin modulators. It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Related Packages: 13107-0082-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Trazodone
Product Information
| NDC | 13107-0082 |
|---|---|
| Product ID | 13107-082_1e82723e-d8ce-4105-8798-cc46c7a5dd85 |
| Associated GPIs | 58120080100325 |
| GCN Sequence Number | 046244 |
| GCN Sequence Number Description | trazodone HCl TABLET 300 MG ORAL |
| HIC3 | H7E |
| HIC3 Description | SEROTONIN-2 ANTAGONIST/REUPTAKE INHIBITORS (SARIS) |
| GCN | 16394 |
| HICL Sequence Number | 001652 |
| HICL Sequence Number Description | TRAZODONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | TRAZODONE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | TRAZODONE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRAZODONE HYDROCHLORIDE |
| Labeler Name | Aurolife Pharma LLC |
| Pharmaceutical Class | Serotonin Reuptake Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204852 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 13107-0082-05 (13107008205)
| NDC Package Code | 13107-082-05 |
|---|---|
| Billing NDC | 13107008205 |
| Package | 500 TABLET in 1 BOTTLE (13107-082-05) |
| Marketing Start Date | 2015-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |